BROMOCRIPTINE IN THE TREATMENT OF RHEUMAT OID PSORIASIS

Citation
F. Eulry et al., BROMOCRIPTINE IN THE TREATMENT OF RHEUMAT OID PSORIASIS, La Presse medicale, 24(35), 1995, pp. 1642-1644
Citations number
23
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
07554982
Volume
24
Issue
35
Year of publication
1995
Pages
1642 - 1644
Database
ISI
SICI code
0755-4982(1995)24:35<1642:BITTOR>2.0.ZU;2-U
Abstract
Non-steroid anti-inflammatory drugs and/or gold salts were unsuccessfu l alone in providing symptom relief in three men with rheumatoid psori asis, All three were treated with bromocriptine (5 mg/d in 2 doses) af ter verification of normal baseline and protirelin-stimulation prolact in levels. There was a beneficial effect in nocturnal pain relief, mor ning stiffness, the Lee and Ritchie scores and biological markers of i nflammation. Two of the patients were able to return to regular work o ccupation after 15 and 45 days. In the third patient, bromocriptine wa s discontinued due to nausea and dizziness but was reintroduced succes sfully in fractionated doses after recurrence of the symptomatology. T reatment was continued without secondary adverse effects for 3 to 9 mo nths providing continued symptom relief. Bromocriptine can be an effec tive adjuvant for the management of rheumatoid psoriasis.